Search

everythinglearnresearchcommunity

for

Search:↓

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hyperbaric oxygen therapy speeds up recovery and improves outcomes in hair transplants.

A woman with PCOS successfully overcame secondary infertility and became pregnant with triplets after treatment.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Robotic hair transplantation surgery is generally effective with high satisfaction rates and minimal complications.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Many women with polycystic ovarian disease show symptoms like excessive hair growth, acne, hair loss, and have high levels of certain hormones.

Laser hair removal is an advanced and effective method for removing unwanted hair.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Women with PCOS have different hormone levels than those without it.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

Loestrin effectively normalizes testosterone levels and improves PCOS symptoms with minimal side effects.